Open Access Open Access  Restricted Access Subscription or Fee Access

Reduction in Schedule II opioid prescribing by primary care providers, orthopedic and general surgeons, and pain management specialists following the implementation of a State House Bill and an Institutional Controlled Substance Task Force

Lisa B. E. Shields, MD, Timothy A. Johnson, BS, Michael W. Daniels, MS, Alisha Bell, MSN, RN, CPN, Diane M. Siemens, PharmD, James T. Jennings, MD, MBA, Steven T. Hester, MD, MBA, Joshua T. Honaker, MD, MBA, FAAP

Abstract


Objective: Prescription opioid misuse represents a social and economic challenge in the United States. We evaluated Schedule II opioid prescribing practices by primary care providers (PCPs), orthopedic and general surgeons, and pain management specialists.

Design: Prospective evaluation of prescribing practices of PCPs, orthopedic and general surgeons, and pain management specialists over 5 years (October 1, 2014-September 30, 2019) in an outpatient setting.

Methods: An analysis of Schedule II opioid prescribing following the implementation of federal and state guidelines and evidence-based standards at our institution.

Results: There were significantly more PCPs, orthopedic and general surgeons, and pain management specialists with a significantly increased number who prescribed Schedule II opioids, whereas there was a simultaneous significant decline in the average number of Schedule II opioid prescriptions per provider, Schedule II opioid pills prescribed per provider, and Schedule II opioid pills prescribed per patient by providers. The average number of Schedule II opioid prescriptions with a quantity >90 and Opana/Oxycontin prescriptions per PCP, orthopedic surgeon, and pain management specialist significantly decreased. The total morphine milligram equivalent (MME)/day of Schedule II opioids ordered by PCPs, orthopedic and general surgeons, and pain management specialists significantly declined. The ages of the providers remained consistent throughout the study.

Conclusions: This study reports the implementation of federal and state regulations and institutional evidence-based guidelines into primary care and medical specialty practices to reduce the number of Schedule II opioids prescribed. Further research is warranted to determine alternative therapies to Schedule II opioids that may alleviate a patient’s pain without initiating or exacerbating a potentially lethal opioid addiction.


Keywords


opioids, primary care providers, orthopedic surgery, general surgery, prescribing practices, morphine milligram equivalent, addiction

Full Text:

PDF

References


Broglio K, Cole BE: Prescribing opioids in primary care: Avoiding perils and pitfalls. Nurse Pract. 2014; 39: 30-37.

Institute of Medicine: Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington, DC: National Academies Press, 2011.

Tobin DG, Andrews R, Becker WC: Prescribing opioids in primary, care: Safely starting, monitoring, and stopping. Cleve Clin J Med. 2016; 83: 207-215.

Smith TJ, Hillner BE: The cost of pain. JAMA Netw Open. 2019; 2: e191532.

Hedegaard H, Minino AM, Warner M: Drug Overdose Deaths in the United States, 1999-2018. NCHS Data Brief, No 356. Hyattsville, MD: National Center for Health Statistics, 2020.

National Safety Council: Accidental deaths hit highest number in recorded US history. Available at https://www.nsc.org/in-thenewsroom/nsc-statement-on-new-cdc-data-showing-a-rise-inaccidental-death. Accessed December 14, 2020.

Guy GP Jr, Zhang K, Bohm MK, et al.: Vital signs: Changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017; 66: 697-704.

Kiang MV, Humphreys K, Cullen MR, et al.: Opioid prescribing patterns among medical providers in the United States, 2003-17: Retrospective, observational study. BMJ. 2020; 368: l6968.

Jamison RN, Sheehan KA, Scanlan E, et al.: Beliefs and attitudes about opioid prescribing and chronic pain management: Survey of primary care providers. J Opioid Manag. 2014; 10: 375-382.

Lagisetty PA, Healy N, Garpestad C, et al.: Access to primary care clinics for patients with chronic pain receiving opioids. JAMA Netw Open. 2019; 2: e196928.

Parchman ML, Von KM, Baldwin LM, et al.: Primary care clinic re-design for prescription opioid management. J Am Board Fam Med. 2017; 30: 44-51.

Tong ST, Hochheimer CJ, Brooks EM, et al.: Chronic opioid prescribing in primary care: Factors and perspectives. Ann Fam Med. 2019; 17: 200-206.

Morris BJ, Mir HR: The opioid epidemic: Impact on orthopaedic surgery. J Am Acad Orthop Surg. 2015; 23: 267-271.

Volkow ND, McLellan TA, Cotto JH, et al.: Characteristics of opioid prescriptions in 2009. JAMA. 2011; 305: 1299-1301.

Heins SE, Frey KP, Alexander GC, et al.: Reducing high-dose opioid prescribing: State-level morphine equivalent daily dose policies, 2007-2017. Pain Med. 2020; 21: 308-316.

Dowell D, Haegerich TM, Chou R: CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep. 2016; 65: 1-49.

Kentucky Cabinet for Health and Family Services: Kentucky All Schedule Prescription Electronic Reporting. Available at https://chfs.ky.gov/agencies/os/oig/dai/deppb/Pages/kasper.aspx. Accessed December 14, 2020.

Freeman PR, Goodin A, Troske S, et al.: Kentucky House Bill 1 impact evaluation. Available at https://www.valueinhealthjournal.com/article/S1098-3015(15)00805-0/fulltext. Accessed December 14, 2020.

Freeman PR, Troske S, Goodin AJ, et al.: Impact of Kentucky House bill 1 on concurrent prescribing of opioid, alprazolam, and carisoprodol. Value Health. 2015; 18: 128.

Shields LBE, Nasraty S, Bell AD, et al.: Primary care providers' prescribing practices of opioid controlled substances. J Opioid Manag. 2016; 12: 397-403.

Shields LBE, Johnson TA, Murphy JP, et al.: Decline in primary care providers’ prescribing of Schedule II opioids following the implementation of federal and state guidelines. J Opioid Manag. 2019; 15: 111-118.

Kampman K, Jarvis M: American Society of Addiction Medicine (ASAM) national practice guideline for the use of medications in the treatment of addiction involving opioid use. J Addict Med. 2015; 9: 358-367.

Murphy JP: Kentucky's updated controlled substances regulations. Louisville Med. 2018; 65(9): 14-16.

Biskup M, Dzioba A, Sowerby LJ, et al.: Opioid prescribing practices following elective surgery in otolaryngology-head & neck surgery. J Otolaryngol Head Neck Surg. 2019; 48: 29.

Brummett CM, Waljee JF, Goesling J, et al.: New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017; 152: e170504.

Ladha KS, Neuman MD, Broms G, et al.: Opioid prescribing after surgery in the United States, Canada, and Sweden. JAMA Netw Open. 2019; 2: e1910734.

Shadbolt C, Abbott JH, Camacho X, et al.: The surgeon's role in the opioid crisis: A narrative review and call to action. Front Surg. 2020; 7: 4.

Kopp JA, Anderson AB, Dickens JF, et al.: Orthopedic surgeon decision-making processes for postsurgical opioid prescribing. Mil Med. 2020; 185: e383-e388.

Overton HN, Hanna MN, Bruhn WE, et al.: Opioid-prescribing guidelines for common surgical procedures: An expert panel consensus. J Am Coll Surg. 2018; 227: 411-418.

Neuman MD, Bateman BT, Wunsch H: Inappropriate opioid prescription after surgery. Lancet. 2019; 393: 1547-1557.

Rose KR, Christie BM, Block LM, et al.: Opioid prescribing and consumption patterns following outpatient plastic surgery procedures. Plast Reconstr Surg. 2019; 143: 929-938.

Brummett CM, Steiger R, Englesbe M, et al.: Effect of an activated charcoal bag on disposal of unused opioids after an outpatient surgical procedure: A randomized clinical trial. JAMA Surg. 2019; 154: 558-561.

Hill MV, Stucke RS, McMahon ML, et al.: An educational intervention decreases opioid prescribing after general surgical operations. Ann Surg. 2018; 267: 468-472.

Hah JM, Bateman BT, Ratliff J, et al.: Chronic opioid use after surgery: Implications for perioperative management in the face of the opioid epidemic. Anesth Analg. 2017; 125: 1733-1740.

Lee D, Armaghani S, Archer KR, et al.: Preoperative opioid use as a predictor of adverse postoperative self-reported outcomes in patients undergoing spine surgery. J Bone Joint Surg Am. 2014; 96: e89.

American Academy of Orthopaedic Surgeons: Opioid use, misue, and abuse in orthopaedic practice. Availabe at https://aaos.org/globalassets/about/bylaws-library/informationstatements/1045-opioid-use-misuse-and-abuse-in-practice.pdf. Accessed December 14, 2020.




DOI: https://doi.org/10.5055/jom.2021.0625

Refbacks

  • There are currently no refbacks.